For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

Studies/Clinical Trials

Diagram of a uterus and ovaries

Vaginal Infection Research Study

Paul Nyirjesy, MD, is currently recruiting patients for participation in a Phase 2 study to evaluate the safety and efficacy of oral Scynexis versus oral fluconazole in subjects with acute vulvovaginal candidiasis (AVVC).

This is a randomized, double-blind, active-controlled, dose-finding study to determine the recommended dose of oral Scynexis. The study will consist of three to four in-office visits within a 25-day period from initial screening.

Eligibility

Participants must (at a minimum):

  • Be 18 years or older and in good general health
  • Have a diagnosis of symptomatic AVVC, including:
    • Moderate to severe AVVC
    • Positive microscopic examination revealing yeast forms or budding yeast
    • Normal vaginal pH
  • Be willing to remain abstinent or use two methods of contraceptive. Acceptable methods of birth control are intrauterine device, condom, hormonal contraceptives and vasectomy (no NuvaRing or spermicide).
  • Not currently:
    • Have any vaginal condition other than AVVC
    • Be menstruating at the time of the baseline visit
    • Have used any vaginal antifungal medication within 28 days prior to consenting
  • Not have uncontrolled diabetes mellitus or a history of cervical/vaginal cancer

Eligible women will receive study-related exams and medication as well as compensation for their time for each visit or procedure.

Learn More or Enroll in the Study

For more information, or if you think you have a patient who might be eligible, please contact:
Marisol Burgos, 215.762.7442 or mb334@drexel.edu


Uterine Fibroid Treatment Study

Dipak Delvadia, DO, is currently recruiting patients for participation in a study to assess the safety and efficacy of Vilaprisan in subjects with uterine fibroids compared to standard of care.

This is an open-label, parallel-group, randomized, multicenter study. It will take between two and three years with multiple office visits, ultrasounds, bone mineral density scans and electronic diary completion.

Eligibility

Participants must (at a minimum):

  • Be 18 years or older
  • Have a diagnosis of uterine fibroids as documented by ultrasound or are high risk for recurrence
  • Currently be having one or more of the following symptoms:
    • Heavy menstrual bleeding
    • Pelvic pressure or pain associated with uterine fibroids
  • Not be pregnant or breastfeeding
  • Be using an acceptable nonhormonal method of contraception

Eligible women will receive study-related exams and medication as well as compensation for their time for each visit or procedure.

Learn More or Enroll in the Study

For more information, or if you think you have a patient who might be eligible, please contact Marisol Burgos at 215.762.7442 or mb334@drexel.edu.


Ovarian Reserve Study

Karen Berkowitz, MD, a reproductive endocrinologist and infertility specialist, and her group in the Drexel Departments of Obstetrics & Gynecology and Biochemistry & Molecular Biology are conducting a research study to identify new biomarkers of ovarian reserve in women. The research aims to advance women's health with a focus in the area of female fertility and to provide women with information to help them make proactive choices about their reproduction. This research has the potential to help the current and next generations of women!

Eligibility

Participation eligibility includes:

  • Age 30–45
  • Regular periods
  • History of at least one birth
  • Not taking hormonal contraceptives or hormones for at least two months (copper IUD okay)

This study is currently recruiting women from the Feinstein and 17th Street patient practices, Drexel/HUH employees, and those referred by word-of-mouth. There is no cost and the study only involves a single blood draw on the second, third or fourth day of the period.

Learn More or Enroll in the Study

Email ovarianstudy2017@gmail.com or call/text 267.702.4616 for more information or to enroll in the study.

The images being used are for illustrative purposes only; any person depicted is a model.

Find a Doctor

Last Name
Specialty